Paper975111
The isolation and characterization of tumor-specific antigens of rodent and human tumors.
Thomson DM and 3 others. Cancer Res, 1976. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The isolation and characterization of tumor-specific antigens of rodent and human tumors. Papers, record 975111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/975111
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The isolation and characterization of tumor-specific antigens of rodent and human tumors.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Breast Neoplasms | Major topic |
| Melanoma | Major topic |
| Sarcoma, Experimental | Major topic |
| Animals | |
| Cell Membrane | |
| Chemical Phenomena | |
| Chemistry | |
| Female | |
| Histocompatibility Antigens | |
| Humans | |
| Leukocytes | |
| Male | |
| Molecular Weight | |
| Rats | |
| Rats, Inbred Strains | |
| Species Specificity |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,362,781 | Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7362781 | PubMed |
| 6,158,964 | Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6158964 | PubMed |
| 443,860 | Human malignant melanoma antigenic properties of phenol water extracts. | Arch Dermatol Res | 1979 | https://conductscience.org/library/papers/443860 | PubMed |
| 369,586 | A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay. | Br J Cancer | 1978 | https://conductscience.org/library/papers/369586 | PubMed |
| 369,585 | The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition. | Br J Cancer | 1978 | https://conductscience.org/library/papers/369585 | PubMed |
| 77,673 | Isolation of human tumour-specific antigens associated with beta2 microglobulin. | Br J Cancer | 1978 | https://conductscience.org/library/papers/77673 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-G | 3,135 | PubTator's text mining | https://conductscience.org/library/genes/3135 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/975111
GET https://conductscience.org/api/papers/v1/975111/authors